Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EOLS – Evolus, Inc.

Evolus, Inc. Common Stock
EOLS
$9.15
Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $589,951,744.00
EPSttm : -0.89
finviz dynamic chart for EOLS
Evolus, Inc. Common Stock
$9.15
2.58%
$0.23

Float Short %

22.15

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

0.19

EPS Last/This Y

0.68

EPS This/Next Y

0.72

Price

9.15

Target Price

23.57

Analyst Recom

1

Performance Q

-22.46

Relative Volume

1.62

Beta

1.12

Ticker: EOLS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04EOLS9.270.040.0017518
2025-07-07EOLS9.140.040.0017518
2025-07-08EOLS9.260.040.1417496
2025-07-09EOLS9.690.040.1717535
2025-07-10EOLS9.730.040.1817620
2025-07-11EOLS9.480.055.0017940
2025-07-14EOLS9.50.050.4017957
2025-07-15EOLS9.270.050.0017955
2025-07-16EOLS9.220.056.0017956
2025-07-17EOLS9.340.050.2917961
2025-07-18EOLS9.210.050.3018014
2025-07-21EOLS9.230.110.164245
2025-07-22EOLS9.560.110.004307
2025-07-23EOLS9.570.100.004923
2025-07-24EOLS9.640.090.015567
2025-07-25EOLS9.530.060.037999
2025-07-28EOLS9.280.080.037281
2025-07-29EOLS9.260.080.497291
2025-07-30EOLS8.970.080.127301
2025-07-31EOLS8.930.090.007460
2025-08-01EOLS9.150.0925.427588
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04EOLS9.27-42.612.0-0.13
2025-07-07EOLS9.14-42.612.4-0.13
2025-07-08EOLS9.26-42.611.8-0.13
2025-07-09EOLS9.66-42.611.1-0.13
2025-07-10EOLS9.73-42.612.0-0.13
2025-07-11EOLS9.48-42.612.5-0.13
2025-07-14EOLS9.50-42.612.1-0.13
2025-07-15EOLS9.27-42.612.7-0.13
2025-07-16EOLS9.20-42.612.3-0.13
2025-07-17EOLS9.34-42.611.8-0.13
2025-07-18EOLS9.22-42.612.4-0.13
2025-07-21EOLS9.24-42.612.0-0.13
2025-07-22EOLS9.57-42.611.3-0.13
2025-07-23EOLS9.58-42.612.1-0.13
2025-07-24EOLS9.65-42.612.0-0.13
2025-07-25EOLS9.53-42.612.4-0.13
2025-07-28EOLS9.30-42.612.7-0.13
2025-07-29EOLS9.25-42.612.2-0.13
2025-07-30EOLS8.96-42.612.8-0.13
2025-07-31EOLS8.92-42.612.2-0.13
2025-08-01EOLS9.15-47.911.5-0.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04EOLS-3.845.5318.60
2025-07-07EOLS-3.845.5018.60
2025-07-08EOLS-3.845.5018.60
2025-07-09EOLS-3.845.5018.60
2025-07-10EOLS-3.845.5018.60
2025-07-11EOLS-3.845.5021.03
2025-07-14EOLS-3.846.2321.03
2025-07-15EOLS-3.846.2321.03
2025-07-16EOLS-3.846.2321.03
2025-07-17EOLS-3.846.2321.03
2025-07-18EOLS-3.846.2321.03
2025-07-21EOLS-3.845.1121.03
2025-07-22EOLS-3.845.1121.03
2025-07-23EOLS-3.845.1121.03
2025-07-24EOLS-3.845.1121.03
2025-07-25EOLS-3.845.1122.15
2025-07-28EOLS-3.844.2522.15
2025-07-29EOLS-3.844.2522.15
2025-07-30EOLS-3.844.2522.15
2025-07-31EOLS-3.844.2522.15
2025-08-01EOLS-3.844.2522.15
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

-3.84

Institutional Transactions

4.25

Beta

1.12

Average Sales Estimate Current Quarter

82

Average Sales Estimate Next Quarter

85

Fair Value

Quality Score

31

Growth Score

52

Sentiment Score

3

Actual DrawDown %

48.7

Max Drawdown 5-Year %

-68.4

Target Price

23.57

P/E

Forward P/E

15.17

PEG

P/S

2.14

P/B

P/Free Cash Flow

EPS

-0.89

Average EPS Est. Cur. Y​

-0.13

EPS Next Y. (Est.)

0.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.4

Relative Volume

1.62

Return on Equity vs Sector %

827.3

Return on Equity vs Industry %

843.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

11.5
Evolus, Inc. Common Stock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 372
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading